Screener Summaries Updates Institutions Sign In More Updates › Earnings › BIO Earnings · Apr 30, 2026
Reports Q1 revenue of $548M as adjusted EPS rises to $1.73 BIO Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories announced its financial results for the first quarter ended March 31, 2026. This filing provides investors with the company's latest quarterly performance data through an accompanying press release and supplemental earnings presentation.
More from Bio-Rad Laboratories, Inc. Bio-Rad Reports Q3 Net Income of $458.6M Driven by Sartorius Investment Gain Nov 4, 2026 Bio-Rad stockholders approve amendment to increase common stock reserve by 335,000 shares Apr 24, 2026 Bio-Rad updates investment in Sartorius AG, which reported €3,538.1 million in sales revenue Feb 19, 2026 Bio-Rad Laboratories reports fourth-quarter financial results for period ended December 31, 2025 Feb 12, 2026 Bio-Rad Laboratories reports third-quarter results for period ended September 30, 2025 Oct 29, 2025 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
